Announcements Trials
Browse Landscape

Phase

Phase 4 4

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Esophageal Neoplasms 4Chemoradiotherapy 1

Interventions

Cisplatin 161Fluorouracil 135Paclitaxel 127Radiotherapy 125Oxaliplatin 88Carboplatin 72Docetaxel 71Irinotecan 60pembrolizumab 57Leucovorin 57Capecitabine 57Radiation 48Esophagectomy 44Surgical Procedures, Operative 42Drug Therapy 38Neoadjuvant Therapy 28Cetuximab 25Nivolumab 24Bevacizumab 21camrelizumab 20Trastuzumab 20S 1 (combination) 19Chemoradiotherapy 19Magnetic Resonance Spectroscopy 18Epirubicin 16Albumin-Bound Paclitaxel 16Blood Specimen Collection 15tislelizumab 14Taxes 14Radiotherapy, Intensity-Modulated 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Esophageal Neoplasms × sodium glycididazole × Clear all
NCT02721550 2019-10-11

A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC

Shandong Cancer Hospital and Institute

Phase 4 Terminated
2 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02721563 2019-10-11

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

Shandong Cancer Hospital and Institute

Phase 4 Completed
77 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02721576 2019-10-11

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

Shandong Cancer Hospital and Institute

Phase 4 Terminated
8 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00642239 2008-05-14

A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

Shandong Luye Pharmaceutical Co., Ltd.

Phase 4 Unknown
48 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡